The key advance in the treatment of sepsis in the last 10 years ... doing less
Author:
Open Access
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 10 (1) , 122
Abstract
Although many pharmaceutical and technological advances are heavily touted, they have had relatively little impact on overall outcome improvements in the critically ill. Acting on the increasing recognition that 'less may be best' has, in my opinion, been the greatest single advance in patient management in the intensive care unit in the past 10 years. Although certainly not qualifying as a 'brave new world' in terms of daring and exciting innovation, the importance of (often covert) iatrogenic complications should not be underestimated.Keywords
This publication has 13 references indexed in Scilit:
- Noninvasive Ventilation in Acute Cardiogenic Pulmonary EdemaJAMA, 2005
- Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern IrelandCritical Care Medicine, 2003
- Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic ShockJAMA, 2002
- Association between mitochondrial dysfunction and severity and outcome of septic shockThe Lancet, 2002
- Terlipressin for norepinephrine-resistant septic shockThe Lancet, 2002
- Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 2001
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill PatientsNew England Journal of Medicine, 1995
- Elevation of Systemic Oxygen Delivery in the Treatment of Critically Ill PatientsNew England Journal of Medicine, 1994